FDA Drug recall D-0892-2018
ESTRADIOL 20mg PELLET, 1-count 3ml amber vial
- FDA Drug
- Class III
- terminated
- Published 2018-07-11
On 2018-07-11 the FDA classified a Class III recall of ESTRADIOL 20mg PELLET, 1-count 3ml amber vial by Qualgen, citing labeling: Incorrect or Missing Lot and/or Exp Date.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0892-2018 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2018-06-08 |
| Published | 2018-07-11 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Qualgen |
| Distribution | US |
Product
ESTRADIOL 20mg PELLET, 1-count 3ml amber vial. RX only. Compounded by: Qualgen 14844 Bristol Park Blvd, Edmond OK 73013. NDC 69761-020-01
Reason
Labeling: Incorrect or Missing Lot and/or Exp Date.
Identifiers
| code_info | lot# C211 Exp. date 10/03/2018; C257 Exp. date 12/14/2018 and lot # D001 exp. date 01/02/19 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0892-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.